Patent · US Active

Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerations

US11717521B2 · kind B2 · utility

0Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 8, 2020
Grant dateAug 8, 2023
Priority date
Expiry dateJul 8, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/19
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a method of treating retinal degenerations, such as but not limited to anterior segment ocular disorders and/or age-related macular degeneration (AMD), in a subject, the method comprising administering to the subject a pharmaceutical composition comprising an effective amount of a compound of formula (1) or formula (2). In a further aspect, the invention provides compounds of formula (2). In certain embodiments, the compounds of the invention prevent or minimize cellular assault, such as oxidative stress-related cellular assault, and/or promote cell viability.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.